Hamps Bio Limited, a prominent player in the pharmaceutical and food processing sectors, recently concluded its Initial Public Offering (IPO) with remarkable success. The IPO, which opened on December 13, 2024, and closed on December 17, 2024, offered 1,220,000 equity shares at a price of ₹51 per share, aiming to raise approximately ₹6.22 crore.
Overwhelming Subscription Response
The IPO witnessed an extraordinary subscription rate, being oversubscribed by 1,003.33 times. Retail Individual Investors (RIIs) showed immense interest, with their segment being oversubscribed by 1,417.96 times, while Non-Institutional Investors (NIIs) subscribed 732.84 times.
Allotment Status and Listing Details
The basis of allotment was finalized on December 18, 2024. Investors who applied for the Hamps Bio IPO can check their allotment status through the following methods:
BSE Website:
- Visit the BSE allotment status page: https://www.bseindia.com/investors/appli_check.aspx
- Select ‘Equity’ as the issue type.
- Choose ‘Hamps Bio Limited’ from the dropdown menu.
- Enter your application number or PAN.
- Click on ‘Search’ to view your allotment status.
Registrar’s Website (Bigshare Services):
- Navigate to the Bigshare Services IPO status page: https://ipo.bigshareonline.com/IPO_Status.html
- Select ‘Hamps Bio Limited’ from the list.
- Provide your application number, PAN, or Beneficiary ID.
- Enter the CAPTCHA code and click ‘Search’ to view your allotment status.
- Post allotment, shares were credited to the investors’ demat accounts on December 19, 2024. The company’s shares debuted on the BSE SME platform on December 20, 2024.
Grey Market Premium (GMP) Insights
Prior to the listing, Hamps Bio’s shares exhibited strong performance in the grey market. On December 18, 2024, the shares were trading at a premium of ₹55, indicating a 107.84% increase over the IPO price of ₹51.
Company Overview
Hamps Bio Limited specializes in the marketing and distribution of pharmaceutical formulation products and the manufacturing of freeze-dried and frozen products. The company operates under two primary brands:
- Hamps: Focused on pharmaceutical products, offering a range of medicines and nutritional supplements.
- FzyEzy: Dedicated to freeze-dried and frozen food products, catering to both domestic and international markets.
The proceeds from the IPO are earmarked for purchasing plant and machinery for the FMCG division, enhancing brand visibility, and general corporate purposes.
Steps to Check Hamps Bio IPO Allotment Status
For investors seeking to verify their allotment status, the following steps can be followed:
- Through BSE Website:
- Visit the BSE allotment status page.
- Select ‘Equity’ as the issue type.
- Choose ‘Hamps Bio Limited’ from the dropdown.
- Enter your application number or PAN.
- Click ‘Search’ to view your status.
- Through Bigshare Services Website:
- Go to the Bigshare Services IPO status page.
- Select ‘Hamps Bio Limited’ from the list.
- Input your application number, PAN, or Beneficiary ID.
- Enter the CAPTCHA and click ‘Search’ to view your status.
For any discrepancies or issues, investors are advised to contact the registrar, Bigshare Services Private Limited, or consult their financial advisors.
Note: Investment in IPOs is subject to market risks. Investors should conduct thorough research or consult financial advisors before making investment decisions.